Articles About CBD and Multiple Sclerosis (MS)

Seizure Free: FDA Approves America’s First Marijuana 
Pharmaceutical
Sam Vogelstein was four years old when he experienced his first . His face suddenly slacked and he abruptly fell forward from the waist. “He did something that looked like a judo bow after a match,” said his mom, Evelyn Nussenbaum. Two months passed before Sam had another seizure. Then the frequency increased. By the... Continue

Cannabidiol Research: Multiple Sclerosis

• Sativex for the management of multiple sclerosis symptoms
• THC & CBD oromucosal spray (Sativex®) in the management of spasticity associated with multiple sclerosis
• Clinical efficacy and effectiveness of Sativex, a combined cannabinoid medicine, in multiple sclerosis-related spasticity
• CBD provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors
• Oromucosal delta9-THC/CBD for neuropathic pain associated with multiple sclerosis
• Nabiximols in the treatment of spasticity, pain and urinary symptoms due to multiple sclerosis
• Sativex long-term use: An open-label trial in patients with spasticity due to multiple sclerosis
• A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis
• Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain
• Sativex: Clinical efficacy and tolerability in the treatment of symptoms of multiple sclerosis and neuropathic pain